ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Agopton 15 mg, magensaftresistente Hartkapseln - 28 Kapsel(n)
51969057 Takeda Pharma AG
Agopton 15 mg, magensaftresistente Hartkapseln18.06.1993
Original11.09.1995
Lansoprazole (A02BC03)22.11.2007
WHO-DDD 
04.99.28 Kapsel(n)
04.99. 
B  
Yes 
IPCI
9.99No
    
20 %27.25
7680519690577Synthetika
1653916 
Composition
lansoprazolum 15 mg, magnesii subcarbonas ponderosus, sacchari sphaerae, saccharum, maydis amylum, hydroxypropylcellulosum substitutum humile, hydroxypropylcellulosum, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum cum natrii laurilsulfas, macrogolum 8000, E 171, polysorbatum 80, talcum, silica colloidalis anhydrica, Kapselhülle: gelatina, aqua, E 171, pro capsula corresp. natrium max. 0.02 mg et saccharum max. 80.3 mg.
Packungsbestandteile
magensaftresistente Hartkapseln 
  
 
Active AgentDose
Lansoprazole15 mg
BAG: Active AgentDose
Lansoprazole15 mg
 
Inactive agentsDoseadditional_information
Acidi Methacrylici  
Aqua  
E 171 color.
Ethylis Acrylatis Polymerisatum Dispersio 30 per Centum cum Natrii Laurilsulfas  
Gelatina Kapselhülle
Hydroxypropylcellulosum  
Hydroxypropylcellulosum Substitutum Humile  
Macrogol8000  
Magnesii Subcarbonas Ponderosus  
Maydis Amylum  
Polysorbatum 80  
Sacchari Sphaerae  
Saccharum  
Silica Colloidalis Anhydrica  
Talcum  
 
Source
Data was imported : 07.05.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home